H
Hiroshi Maeda
Researcher at Kumamoto University
Publications - 915
Citations - 67944
Hiroshi Maeda is an academic researcher from Kumamoto University. The author has contributed to research in topics: Neocarzinostatin & Nitric oxide. The author has an hindex of 103, co-authored 893 publications receiving 63370 citations. Previous affiliations of Hiroshi Maeda include Osaka University & Okayama University.
Papers
More filters
Journal ArticleDOI
Flory exponent of the chain of the expanding polyion gel
TL;DR: In this paper, a theory to describe the swelling behavior of polyion gels is presented on the basis of de Gennes theory for the conformational entropy of chains under traction and ideal Donnan approximation combined with the counterion condensation of polyelectrolytes for the osmotic expansion force.
Journal Article
Malignant lymphomas and related conditions involving nasal cavity and paranasal sinuses: a clinicopathologic study of forty-two cases with emphasis on prognostic factors.
TL;DR: Clinopathologic findings in 42 patients with lymphoproliferative diseases involving the nasal cavity and paranasal sinuses were reviewed, and favourable prognostic factors assessed were ordinary lymphoma, stage I disease, absence of ulceration in the lesions, and a tendency for local tumor formation.
Patent
Electrical contact material of silver base alloy
TL;DR: An electrical contact material consisting essentially of silver and a small amount of zinc oxide, tellurium oxide, and optionally indium oxide and tin oxide, these oxides being uniformly dispersed in the silver matrix.
Journal ArticleDOI
Extracts of Phellinus linteus, Bamboo (Sasa senanensis) Leaf and Chaga Mushroom (Inonotus obliquus) Exhibit Antitumor Activity through Activating Innate Immunity.
TL;DR: The findings suggest the potential application of MeshimaMax for cancer prevention and as supplement regimen for anticancer chemotherapy, probably functioning through activation of innate immunity, which may benefit cancer patients as an alternative supplement.
Journal ArticleDOI
Fluorescence polarization with FDA in leukaemic cells: a clear difference between myelogenous and lymphocytic origins.
TL;DR: The use of FDA for the determination of IFP appears to be useful for differential diagnosis, at least between acute myelogenous and lymphocytic leukaemias, and there seemed little evidence for the existence of any such dyebinding protein(s).